Labetalol hydrochloride and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Labetalol hydrochloride (labetalol hydrochloride) and Zolpidem (zolpidem tartrate). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Labetalol hydrochloride and Zolpidem. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Labetalol hydrochloride?

Labetalol hydrochloride has active ingredients of labetalol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,413 Labetalol hydrochloride users. Check the latest studies of Labetalol hydrochloride.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.

On Jul, 15, 2026

21 people who take Labetalol hydrochloride and Zolpidem together, and have interactions are studied.

Labetalol hydrochloride and Zolpidem drug interactions.

What are the common drug interactions of Labetalol Hydrochloride and Zolpidem, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Anxiety
Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Eye movement disorder
Fall
Malaise (a feeling of general discomfort or uneasiness)
Renal tubular necrosis (death of kidney tubules)
Sinus bradycardia (an unusually slow heartbeat due to heart disease)

male:

Chronic kidney disease
Abdominal discomfort
Confusional state
Contusion (a type of hematoma of tissue in which capillaries)
Death
Dizziness
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)

What are the common drug interactions of Labetalol Hydrochloride and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Calcinosis (calcium deposits in any soft tissue)
Chronic kidney disease
Emotional distress
Pain

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)
Abdominal discomfort
Abnormal dreams
Anxiety
Back pain
Blood potassium decreased
Body temperature increased
Catheter site pain
Chest pain
Chronic kidney disease

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Completed suicide (act of taking one's own life)

60+:

Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Blood glucose increased
Bruxism (habitual grinding of the teeth, typically during sleep)
Choreoathetosis (involuntary movement randomly from one part to another body part)
Death
Drug hypersensitivity
Failure to thrive (inadequate weight gain and physical growth in children)
Hospitalisation
Malignant neoplasm progression (cancer tumour came back)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 28.57%
Stress And Anxiety: 3 people, 14.29%
Hypokalemia (low potassium): 3 people, 14.29%
High Blood Cholesterol: 3 people, 14.29%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 14.29%
Prostate Infection: 2 people, 9.52%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Diabetes: 2 people, 9.52%
Depression: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Labetalol hydrochloride and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously